{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:45:56Z","timestamp":1794584756018,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003017"],"award-info":[{"award-number":["82003017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Public Welfare Research Project","award":["LGF21H060004"],"award-info":[{"award-number":["LGF21H060004"]}]},{"name":"Zhejiang Provincial Public Welfare Research Project","award":["LGF22H060025"],"award-info":[{"award-number":["LGF22H060025"]}]},{"name":"Zhejiang Provincial Medical and Health Technology Project","award":["2022RC228"],"award-info":[{"award-number":["2022RC228"]}]},{"name":"Zhejiang Provincial Medical and Health Technology Project","award":["2022519575"],"award-info":[{"award-number":["2022519575"]}]},{"name":"Hangzhou Science and Technology Development Project","award":["20191203B87"],"award-info":[{"award-number":["20191203B87"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoarthritis (OA), in which macrophage-driven synovitis is considered closely related to cartilage destruction and could occur at any stage, is an inflammatory arthritis. However, there are no effective targets to cure the progression of OA. The NOD-, LRR-,and pyrin domain-containing protein 3 (NLRP3) inflammasome in synovial macrophages participates in the pathological inflammatory process and treatment strategies targeting it are considered to be an effective approach for OA. PIM-1 kinase, as a downstream effector of many cytokine signaling pathways, plays a pro-inflammatory role in inflammatory disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we evaluated the expression of the PIM-1 and the infiltration of synovial macrophages in the human OA synovium. The effects and mechanism of PIM-1 were investigated in mice and human macrophages stimulated by lipopolysaccharide (LPS) and different agonists such as nigericin, ATP, Monosodium urate (MSU), and Aluminum salt (Alum). The protective effects on chondrocytes were assessed by a modified co-culture system induced by macrophage condition medium (CM). The therapeutic effect in vivo was confirmed by the medial meniscus (DMM)-induced OA in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The expression of PIM-1 was increased in the human OA synovium which was accompanied by the infiltration of synovial macrophages. In vitro experiments, suppression of PIM-1 by SMI-4a, a specific inhibitor, rapidly inhibited the NLRP3 inflammasome activation in mice and human macrophages and gasdermin-D (GSDME)-mediated pyroptosis. Furthermore, PIM-1 inhibition specifically blocked the apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization in the assembly stage. Mechanistically, PIM-1 inhibition alleviated the mitochondrial reactive oxygen species (ROS)\/chloride intracellular channel proteins (CLICs)-dependent Cl\n                      <jats:sup>\u2212<\/jats:sup>\n                      efflux signaling pathway, which eventually resulted in the blockade of the ASC oligomerization and NLRP3 inflammasome activation. Furthermore, PIM-1 suppression showed chondroprotective effects in the modified co-culture system. Finally, SMI-4a significantly suppressed the expression of PIM-1 in the synovium and reduced the synovitis scores and the Osteoarthritis Research Society International (OARSI) score in the DMM-induced OA model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Therefore, PIM-1 represented a new class of promising targets as a treatment of OA to target these mechanisms in macrophages and widened the road to therapeutic strategies for OA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04313-1","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T03:02:12Z","timestamp":1688785332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS\/Cl\u2212 efflux signaling pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangxiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuepeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-8817","authenticated-orcid":false,"given":"Liulong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"issue":"10","key":"4313_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrrheum.2015.95","volume":"11","author":"T Pap","year":"2015","unstructured":"Pap T, Korb-Pap A. Cartilage damage in osteoarthritis and rheumatoid arthritis\u2013two unequal siblings. Nat Rev Rheumatol. 2015;11(10):606\u201315.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4313_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/j.pain.0000000000002174","volume":"162","author":"LA Pattison","year":"2021","unstructured":"Pattison LA, et al. Cell-cell interactions in joint pain: rheumatoid arthritis and osteoarthritis. Pain. 2021;162(3):714\u20137.","journal-title":"Pain"},{"issue":"9","key":"4313_CR3","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.joca.2016.04.010","volume":"24","author":"VB Kraus","year":"2016","unstructured":"Kraus VB, et al. Direct in vivo evidence of activated macrophages in human osteoarthritis. Osteoarthritis Cartilage. 2016;24(9):1613\u201321.","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"4313_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1136\/annrheumdis-2017-212647","volume":"77","author":"M Zeisbrich","year":"2018","unstructured":"Zeisbrich M, et al. Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation. Ann Rheum Dis. 2018;77(7):1053\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4313_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12608","volume":"281","author":"MM Hughes","year":"2018","unstructured":"Hughes MM, O\u2019Neill LAJ. Metabolic regulation of NLRP3. Immunol Rev. 2018;281(1):88\u201398.","journal-title":"Immunol Rev"},{"issue":"12","key":"4313_CR6","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012\u201321.","journal-title":"Trends Biochem Sci"},{"key":"4313_CR7","doi-asserted-by":"publisher","first-page":"1472567","DOI":"10.1155\/2016\/1472567","volume":"2016","author":"D Clavijo-Cornejo","year":"2016","unstructured":"Clavijo-Cornejo D, et al. The overexpression of NALP3 inflammasome in knee osteoarthritis is associated with synovial membrane prolidase and NADPH Oxidase 2. Oxid Med Cell Longev. 2016;2016:1472567.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"4313_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cei.13167","volume":"194","author":"C Guo","year":"2018","unstructured":"Guo C, et al. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clin Exp Immunol. 2018;194(2):231\u201343.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"4313_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.joca.2018.02.901","volume":"26","author":"MJ McAllister","year":"2018","unstructured":"McAllister MJ, et al. NLRP3 as a potentially novel biomarker for the management of osteoarthritis. Osteoarthritis Cartilage. 2018;26(5):612\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"4313_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11(8):633\u201352.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"4313_CR11","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He WT, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Res. 2015;25(12):1285\u201398.","journal-title":"Cell Res"},{"issue":"8","key":"4313_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3772","volume":"18","author":"IS Afonina","year":"2017","unstructured":"Afonina IS, et al. Limiting inflammation-the negative regulation of NF-\u03baB and the NLRP3 inflammasome. Nat Immunol. 2017;18(8):861\u20139.","journal-title":"Nat Immunol"},{"issue":"8","key":"4313_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"4313_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(8):588\u2013606.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"4313_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, N\u00fa\u00f1ez G. The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci. 2023;48(4):331\u2013344.","journal-title":"Trends Biochem Sci"},{"issue":"7575","key":"4313_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660\u20135.","journal-title":"Nature"},{"issue":"5","key":"4313_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","volume":"180","author":"K Wang","year":"2020","unstructured":"Wang K, et al. Structural mechanism for GSDMD Targeting by Autoprocessed Caspases in pyroptosis. Cell. 2020;180(5):941-955e20.","journal-title":"Cell"},{"key":"4313_CR18","doi-asserted-by":"publisher","first-page":"607186","DOI":"10.3389\/fmed.2020.607186","volume":"7","author":"C Lambert","year":"2020","unstructured":"Lambert C, et al. The Damage-Associated molecular patterns (DAMPs) as potential targets to treat osteoarthritis: perspectives from a review of the literature. Front Med (Lausanne). 2020;7:607186.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"4313_CR19","first-page":"48","volume":"37","author":"M Millerand","year":"2019","unstructured":"Millerand M, Berenbaum F, Jacques C. Danger signals and inflammaging in osteoarthritis. Clin Exp Rheumatol. 2019;37(5):48\u201356.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4313_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-020-0109-y","volume":"5","author":"S Luszczak","year":"2020","unstructured":"Luszczak S, et al. PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer. Signal Transduct Target Ther. 2020;5(1):7.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"4313_CR21","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1172\/JCI26273","volume":"115","author":"R Amaravadi","year":"2005","unstructured":"Amaravadi R, Thompson CB. The survival kinases akt and pim as potential pharmacological targets. J Clin Invest. 2005;115(10):2618\u201324.","journal-title":"J Clin Invest"},{"issue":"1","key":"4313_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/key261","volume":"58","author":"YJ Ha","year":"2019","unstructured":"Ha YJ, et al. PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology (Oxford). 2019;58(1):154\u201364.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4313_CR23","first-page":"727","volume":"7","author":"M Lilly","year":"1992","unstructured":"Lilly M, et al. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene. 1992;7(4):727\u201332.","journal-title":"Oncogene"},{"issue":"14","key":"4313_CR24","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.3390\/ijms21145138","volume":"21","author":"HS Baek","year":"2020","unstructured":"Baek HS, et al. Anti-inflammatory Effects of the novel PIM kinase inhibitor KMU-470 in RAW 264.7 cells through the TLR4-NF-\u03baB-NLRP3 pathway. Int J Mol Sci. 2020;21(14):5138.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4313_CR25","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2141.2006.06225.x","volume":"134","author":"KT Kim","year":"2006","unstructured":"Kim KT, Levis M, Small D. Constitutively activated FLT3 phosphorylates BAD partially through pim-1. Br J Haematol. 2006;134(5):500\u20139.","journal-title":"Br J Haematol"},{"issue":"1","key":"4313_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1158\/1078-0432.CCR-16-0230","volume":"23","author":"T Pa\u00edno","year":"2017","unstructured":"Pa\u00edno T, et al. The novel Pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of Care. Clin Cancer Res. 2017;23(1):225\u201338.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4313_CR27","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/art.41744","volume":"73","author":"NJ Maney","year":"2021","unstructured":"Maney NJ, et al. Pim Kinases as therapeutic targets in early rheumatoid arthritis. Arthritis Rheumatol. 2021;73(10):1820\u201330.","journal-title":"Arthritis Rheumatol"},{"key":"4313_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molimm.2020.06.013","volume":"125","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. Inhibition of PIM1 kinase attenuates bleomycin-induced pulmonary fibrosis in mice by modulating the ZEB1\/E-cadherin pathway in alveolar epithelial cells. Mol Immunol. 2020;125:15\u201322.","journal-title":"Mol Immunol"},{"issue":"1","key":"4313_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00011-020-01420-3","volume":"70","author":"Y Cao","year":"2021","unstructured":"Cao Y, et al. PIM1 inhibition attenuated endotoxin-induced acute lung injury through modulating ELK3\/ICAM1 axis on pulmonary microvascular endothelial cells. Inflamm Res. 2021;70(1):89\u201398.","journal-title":"Inflamm Res"},{"issue":"1","key":"4313_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor M, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33\u201342.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"4313_CR31","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/rheumatology\/ker524","volume":"51","author":"N Busso","year":"2012","unstructured":"Busso N, So A. Microcrystals as DAMPs and their role in joint inflammation. Rheumatology (Oxford). 2012;51(7):1154\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"7081","key":"4313_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"issue":"10\u201312","key":"4313_CR33","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1089\/ars.2020.8257","volume":"36","author":"A Dominic","year":"2022","unstructured":"Dominic A, Le NT, Takahashi M. Loop between NLRP3 inflammasome and reactive oxygen species. Antioxid Redox Signal. 2022;36(10\u201312):784\u201396.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"4313_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41467-017-00227-x","volume":"8","author":"T Tang","year":"2017","unstructured":"Tang T, et al. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat Commun. 2017;8(1):202.","journal-title":"Nat Commun"},{"issue":"12","key":"4313_CR35","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1038\/s41388-020-1168-9","volume":"39","author":"SS Chauhan","year":"2020","unstructured":"Chauhan SS, et al. PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer. Oncogene. 2020;39(12):2597\u2013611.","journal-title":"Oncogene"},{"key":"4313_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2298865","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang X, et al. Inhibition of CEBPB attenuates Lupus Nephritis via regulating Pim-1 signaling. Mediators Inflamm. 2022;2022: 2298865.","journal-title":"Mediators Inflamm"},{"issue":"8","key":"4313_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/art.40863","volume":"71","author":"R Fu","year":"2019","unstructured":"Fu R, et al. Pim-1 as a therapeutic target in Lupus Nephritis. Arthritis Rheumatol. 2019;71(8):1308\u201318.","journal-title":"Arthritis Rheumatol"},{"issue":"40","key":"4313_CR38","doi-asserted-by":"publisher","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","volume":"115","author":"JP Green","year":"2018","unstructured":"Green JP, et al. Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc Natl Acad Sci U S A. 2018;115(40):E9371-80.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4313_CR39","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.apsb.2022.02.010","volume":"12","author":"Z Sun","year":"2022","unstructured":"Sun Z, et al. Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling. Acta Pharm Sin B. 2022;12(7):3073\u201384.","journal-title":"Acta Pharm Sin B"},{"issue":"Suppl 3","key":"4313_CR40","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","volume":"18","author":"SS Glasson","year":"2010","unstructured":"Glasson SS, et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010;18(Suppl 3):S17-23.","journal-title":"Osteoarthritis Cartilage"},{"issue":"10","key":"4313_CR41","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1182\/blood-2008-04-149419","volume":"112","author":"SA Didichenko","year":"2008","unstructured":"Didichenko SA, et al. IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood. 2008;112(10):3949\u201358.","journal-title":"Blood"},{"issue":"12","key":"4313_CR42","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1182\/blood.V84.12.4135.bloodjournal84124135","volume":"84","author":"O Miura","year":"1994","unstructured":"Miura O, et al. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood. 1994;84(12):4135\u201341.","journal-title":"Blood"},{"issue":"5","key":"4313_CR43","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41423-020-0444-5","volume":"18","author":"B Huang","year":"2021","unstructured":"Huang B, et al. Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y(12) signaling pathway. Cell Mol Immunol. 2021;18(5):1278\u201389.","journal-title":"Cell Mol Immunol"},{"key":"4313_CR44","doi-asserted-by":"publisher","first-page":"661811","DOI":"10.3389\/fimmu.2021.661811","volume":"12","author":"A Trachalaki","year":"2021","unstructured":"Trachalaki A, et al. Enhanced IL-1\u03b2 release following NLRP3 and AIM2 inflammasome stimulation is linked to mtROS in Airway Macrophages in Pulmonary Fibrosis. Front Immunol. 2021;12:661811.","journal-title":"Front Immunol"},{"issue":"1","key":"4313_CR45","doi-asserted-by":"publisher","first-page":"19091","DOI":"10.1038\/s41598-020-76251-7","volume":"10","author":"H Ahn","year":"2020","unstructured":"Ahn H, Lee GS. Riboflavin, vitamin B2, attenuates NLRP3, NLRC4, AIM2, and non-canonical inflammasomes by the inhibition of caspase-1 activity. Sci Rep. 2020;10(1):19091.","journal-title":"Sci Rep"},{"issue":"5","key":"4313_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.apsb.2019.01.015","volume":"9","author":"F Zhou","year":"2019","unstructured":"Zhou F, et al. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-\u03baB\/MAPK signaling and protecting chondrocytes. Acta Pharm Sin B. 2019;9(5):973\u201385.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"4313_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","volume":"18","author":"E Sanchez-Lopez","year":"2022","unstructured":"Sanchez-Lopez E, et al. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022;18(5):258\u201375.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"4313_CR48","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1080\/15548627.2019.1664705","volume":"16","author":"B Zhang","year":"2020","unstructured":"Zhang B, et al. SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B\/IL-1\u03b2 and contributes to LIPUS-mediated anti-inflammatory effect. Autophagy. 2020;16(7):1262\u201378.","journal-title":"Autophagy"},{"issue":"8","key":"4313_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1586\/14779072.2013.814830","volume":"11","author":"S Siddiqi","year":"2013","unstructured":"Siddiqi S, Sussman MA. Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase. Expert Rev Cardiovasc Ther. 2013;11(8):949\u201357.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"4313_CR50","doi-asserted-by":"publisher","first-page":"160589","DOI":"10.1016\/j.scitotenv.2022.160589","volume":"861","author":"T Wu","year":"2023","unstructured":"Wu T, Li Z, Wei Y. Advances in understanding mechanisms underlying mitochondrial structure and function damage by ozone. Sci Total Environ. 2023;861:160589.","journal-title":"Sci Total Environ"},{"issue":"1","key":"4313_CR51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13287-022-03005-9","volume":"13","author":"H Zhou","year":"2022","unstructured":"Zhou H, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage. Stem Cell Res Ther. 2022;13(1):322.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4313_CR52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41374-018-0135-3","volume":"99","author":"X Wu","year":"2019","unstructured":"Wu X, et al. The role of ca(2+) in acid-sensing ion channel 1a-mediated chondrocyte pyroptosis in rat adjuvant arthritis. Lab Invest. 2019;99(4):499\u2013513.","journal-title":"Lab Invest"},{"key":"4313_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","volume":"44","author":"T Wang","year":"2018","unstructured":"Wang T, He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38\u201350.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"4313_CR54","doi-asserted-by":"publisher","first-page":"103207","DOI":"10.1016\/j.autrev.2022.103207","volume":"21","author":"F Caso","year":"2022","unstructured":"Caso F, et al. Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3\/4 and FOXP3) activation. Autoimmun Rev. 2022;21(12):103207.","journal-title":"Autoimmun Rev"},{"key":"4313_CR55","doi-asserted-by":"publisher","first-page":"114935","DOI":"10.1016\/j.bcp.2022.114935","volume":"198","author":"L Ni","year":"2022","unstructured":"Ni L, et al. Itaconate attenuates osteoarthritis by inhibiting STING\/NF-\u03baB axis in chondrocytes and promoting M2 polarization in macrophages. Biochem Pharmacol. 2022;198:114935.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4313_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.joca.2014.09.006","volume":"23","author":"KA Elsaid","year":"2015","unstructured":"Elsaid KA, et al. The impact of early intra-articular administration of interleukin-1 receptor antagonist on lubricin metabolism and cartilage degeneration in an anterior cruciate ligament transection model. Osteoarthritis Cartilage. 2015;23(1):114\u201321.","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04313-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04313-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04313-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T04:02:47Z","timestamp":1688788967000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04313-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4313"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04313-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2978790\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mice: The wild-type and healthy C57BL\/6 male mice were purchased from the Shanghai SLAC Laboratory Animal Company (Shanghai, China) and used in almost all our experiments. The study was authorized by Laboratory animal management and ethics committee of ZCMU (No. IACUC-20220214-03). Human: The ethics approval (KY-20230117-0008-01, KY-20230419-0075-01) was stamped by the Ethics Committee of Hangzhou First People\u2019s Hospital, which was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}